5th Wet AMD and Diabetic Eye Disease Drug Summit

13 13 people viewed this event.

Global biopharmaceutical leaders continue to make significant strides in retinal disease treatments; as Bayer and Regeneron make headway with its high-dose version of Eylea (Eylea HD), Roche’s Vabysmo is providing strong competition and has rapidly increased its market share across wet AMD and DME.

 

Date and Time: Tuesday, 18 March 2025 at 08:00 to Thursday, 20 March 2025 at 16:20

Venue details: Revere Hotel Boston Common, 200 Stuart Street, Boston, Massachusetts, 02116, United States

 

Contact Person - Eden Chau

Email - info@hansonwade.com

Organizer - Hanson Wade

 

Dates

18 Mar. 2025
20 Mar. 2025
 

City

Boston
 

Country

 

Topic Area

Share With Colleagues